Priya Patel

Dr. Priya Patel brings a rare combination of medical expertise and financial acumen to healthcare investing. After completing her MD at Johns Hopkins and a residency in oncology, she surprised colleagues by pursuing an MBA from Harvard Business School. She spent five years at a leading biotech hedge fund before launching her own research platform. Priya has an uncanny ability to read between the lines of clinical trial data and FDA filings, spotting winners and losers months before the market catches on. Her call on Moderna's COVID vaccine potential in early 2020 generated legendary returns. She's equally skilled at identifying overvalued biotechs with weak pipelines, saving her followers from costly mistakes. Priya understands both the science and the business of medicine, translating complex pharmacology into actionable investment insights. She operates from Boston's biotech hub, frequently attending medical conferences and maintaining relationships with researchers at leading institutions.